BCR/ABL can promote CD19(+) cell growth but not render them long-term stemness

類似資料

• Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
  著者:: Baum, Karina J, 等
  出版事項: (2008)
• BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
  著者:: Schemionek, Mirle, 等
  出版事項: (2010)
• Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
  著者:: Xinhua Xiao, 等
  出版事項: (2020-06-01)
• Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition
  著者:: Xiao, Xinhua, 等
  出版事項: (2020)
• Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder
  著者:: Hao, Sheryl X., 等
  出版事項: (2000)